Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
View Older Stories View More Recent Stories
-
Pre-Open Stock Movers 02/16: (ADT) (GRPN) (CSIQ) Higher; (TNXP) (GOGO) (CYH) Lower (more...)
-
Second Sight Medical (EYES) Announces Publication of Positive Argus II Phase 3 Data
-
Second Sight Announces Publication of Positive Results in 3-Year FLORA Study of the Argus II
-
Second Sight to Present at RBC Capital Markets 2016 Global Healthcare Conference and Host Meetings at 2016 BTIG MedTech Conference
-
Second Sight Announces Exclusive Agreement with Tecnosalud to Bring the Argus II Retinal Prosthesis to Argentina
-
Second Sight Files S-1 Registration Statement for Rights Offering to Shareholders
-
Second Sight Medical (EYES) Updates on 2015 Performance Metrics; 21 Argus II Retinal Prosthesis Systems Implants Made
-
Second Sight Provides Business Update and Key Performance Metrics for Full Year 2015
-
Second Sight Medical Products, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Second Sight Medical (EYES) Says Meeting with CMS Related to Argus II Didn't Result in Revision of Final Rule
-
Second Sight to Present at Piper Jaffray 27th Annual Healthcare Conference
-
Second Sight Reports Third Quarter 2015 Financial Results
-
Second Sight to Discuss 2015 Third Quarter Financial Results on October 29, 2015 Conference Call
-
Second Sight to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
-
Second Sight Reports Second Quarter 2015 Financial Results
-
Second Sight to Discuss 2015 Second Quarter Financial Results on August 4, 2015 Conference Call
-
Pre-Open Stock Movers 07/22: (ISRG) (THOR) (EYES) Higher; (XOMA) (ILMN) (AAPL) Lower (more...)
-
Second Sight Medical (EYES) Announces First Implant, Successful Activation of Argus II in AMD
-
Second Sight Announces First Age-Related Macular Degeneration Patient Receives the Argus II Retinal Prosthesis System as Part of Groundbreaking Study
-
Second Sight Medical (EYES) Announces First Argus II Implants Made in Turkey, Austria
-
Second Sight Announces Expansion of Argus II Availability in Europe
-
Second Sight Medical (EYES) Names Will McGuire as President, CEO
-
Second Sight Appoints Will McGuire as President and CEO
-
Second Sight Medical (EYES) Reports Positive Long Term Post-Implant Results of Argus II
-
Second Sight Announces Positive Long-Term Results of the Argus II Retinal Prosthesis System
-
Second Sight to Present at JMP Securities Life Sciences Conference
-
Second Sight to Present at JMP Securities Life Sciences Conference
-
Pre-Open Stock Movers 06/04: (BRLI) (AVEO) (FIVE) Higher; (MCP) (DRWI) (OPK) Lower (more...)
-
After-Hours Stock Movers 06/03: (FIVE) (FEYE) (EYES) Higher; (DRWI) (SGMO) (BLUE) Lower (more...)
-
Second Sight Medical (EYES) Says MAC for Ohio, Kentucky Agreed to Cover Implantation of Argus II
-
Second Sight Medical (EYES) Adds MannKind's Pfeffer as Director
-
Second Sight Appoints Matthew J. Pfeffer to Its Board of Directors
-
Second Sight to Present at Investor Conference on June 4, 2015
-
Second Sight Medical (EYES) Will be Featured on '60 Minutes'
-
Second Sight Reports First Quarter 2015 Financial Results
-
Second Sight Announces Exclusive Agreement With Gulf Medical Company to Distribute the Argus II Retinal Prosthesis System in Saudi Arabia
-
Second Sight Announces Senior Management Appointments in Commercialization and Manufacturing
-
Second Sight to Discuss 2015 First Quarter Financial Results on May 13, 2015 Conference Call
-
Second Sight Medical (EYES) Successfully Implants Model of Orion I Visual Cortical Prosthesis
-
Second Sight Announces First Successful Implant of Model of Orion I Visual Cortical Prosthesis
-
Second Sight Announces First Successful Implant of Model of Orion I Visual Cortical Prosthesis
-
Second Sight Reports Fourth Quarter and Year End 2014 Financial Results and Provides Business Update
-
Unusual 11 Mid-Day Movers 3/5: (PEIX) (EYES) (KYTH) Higher; (CAPN) (DRAM) (GEF) Lower
-
Pre-Open Stock Movers 03/05: (KYTH) (PCYC) (KR) Higher; (BRLI) (JOY) (ABBV) Lower (more...)
-
Second Sight Medical (EYES) Reports Successful First Implants at Two New Centers in Italy
-
Second Sight Announces Successful First Implants of the ArgusĀ® II Retinal Prosthesis System at Two New Centers in Italy
-
Unusual 11 Mid-Day Movers 02/25: (BNFT) (CLRX) (ONFC) Higher; (WBAI) (LL) (ARC) Lower
-
Second Sight Medical (EYES) Gains for Second Session Following French Approval of Argus II
-
Unusual 11 Mid-Day Movers 2/24: (BIOC) (CHGG) (APRI) Higher; (CBAY) (TAX) (DAKT) Lower
-
Pre-Open Stock Movers 02/24: (SPWR) (FSLR) (EYES) (CHGG) Higher; (ROSE) (WIN) (PDLI) Lower (more...)

